title: The importance of RT-qPCR primer design for the detection of siRNA-mediated mRNA silencing.
abstract: BACKGROUND
  The use of RNAi to analyse gene function in vitro is now widely applied in biological research. However, several difficulties are associated with its use in vivo, mainly relating to inefficient delivery and non-specific effects of short RNA duplexes in animal models. The latter can lead to false positive results when real-time RT-qPCR alone is used to measure target mRNA knockdown.
  
  
  RESULTS
  We observed that detection of an apparent siRNA-mediated knockdown in vivo was dependent on the primers used for real-time RT-qPCR measurement of the target mRNA. Two siRNAs specific for RRM1 with equivalent activity in vitro were administered to A549 xenografts via intratumoural injection. In each case, apparent knockdown of RRM1 mRNA was observed only when the primer pair used in RT-qPCR flanked the siRNA cleavage site. This false-positive result was found to result from co-purified siRNA interfering with both reverse transcription and qPCR.
  
  
  CONCLUSIONS
  Our data suggest that using primers flanking the siRNA-mediated cleavage site in RT-qPCR-based measurements of mRNA knockdown in vivo can lead to false positive results. This is particularly relevant where high concentrations of siRNA are introduced, particularly via intratumoural injection, as the siRNA may be co-purified with the RNA and interfere with downstream enzymatic steps. Based on these results, using primers flanking the siRNA target site should be avoided when measuring knockdown of target mRNA by real-time RT-qPCR.
authors: Genesis Research & Development Corporation, Ltd, PO Box 50, Auckland 1140, New Zealand. glen.reid@sydney.edu.au.
authors: Mike
authors: M
authors: Herbert
authors: Natacha
authors: N
authors: Coppieters
authors: Annette
authors: A
authors: Lasham
authors: Helen
authors: H
authors: Cao
authors: Glen
authors: G
authors: Reid
references: Nature. 2008 Apr 3;452(7187):591-7
references: 18368052
references: Nat Rev Drug Discov. 2009 Feb;8(2):129-38
references: 19180106
references: Nucleic Acids Res. 2010 Jan;38(3):e19
references: 19942683
references: PLoS One. 2010 Feb 15;5(2):e9219
references: 20169152
references: Anal Biochem. 2005 Sep 15;344(2):287-8
references: 16004954
references: Gene Ther. 2009 May;16(5):579-80
references: 19262612
references: Hum Gene Ther. 2008 Oct;19(10):991-9
references: 18713023
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: BMC Res Notes. 2010 Mar 03;3:53
references: 20199660
references: Annu Rev Biomed Eng. 2006;8:377-402
references: 16834561
references: J RNAi Gene Silencing. 2009 Mar 09;5(1):321-30
references: 19771229
references: Mol Ther. 2006 Apr;13(4):644-70
references: 16481219
references: Oligonucleotides. 2009 Dec;19(4):317-28
references: 19943803
references: Biomol Eng. 2004 Nov;21(3-5):113-7
references: 15567105
references: Oligonucleotides. 2009 Jun;19(2):89-102
references: 19441890